Drugs / OFD with ALN
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02516111 Comparator | Sep 2014 → May 2015 | chronic periodontitis | Government Dental College and Research Institute, Bangalore | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OFD with ALN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02516111 ↗ |
| Action | Inhibit | “Alendronate and Atorvastatin are known to inhibit osteoclastic bone resorption” NCT02516111 ↗ |